NYSE

Labcorp Holdings Inc. (LH)

589 Thanks from members

Labcorp Holdings Inc. (LH) exhibits strong 2026 financial momentum, driven by specialty testing growth, upgraded full-year guidance, and new companion diagnostic approvals, though tempered by a rich valuation trading near 52-week highs.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →